|
Match
|
Document |
Document Title |
|
|
US20110118818 |
ENCAPSULATED OR COATED STENT SYSTEMS
A stent system comprising zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix... |
|
|
US20110172753 |
ENDOPROSTHESES
Endoprosthesis are disclosed. |
|
|
US20140379073 |
VASCULAR STENT WITH A MIXED CONFIGURATION OF CONNECTORS
This invention provides for a radially expandable stent having superior strength and reduced foreshortening properties. The stents have a mixed configuration of straight and arcuate connector... |
|
|
US20120041540 |
STENT TO BE USED IN TUBULAR ORGAN IN VIVO
Provided is a stent to be inserted into an in vivo organ having a tubular structure that allows a degree of freedom in design and excellent mechanical flexibility. A cylinder-shaped stent is... |
|
|
US20120150281 |
IMPLANT MADE OF BIOCORRODIBLE MATERIAL AND WITH A COATING CONTAINING A TISSUE ADHESIVE
The invention relates to an implant having a base body made of a biocorrodible material. A surface of the implant has a coating at least in some regions, wherein the coating comprises a tissue... |
|
|
US20140277399 |
TISSUE ADHESIVE COATINGS FOR DRUG COATED BALLOON
A therapeutic formulation is described for a drug delivery balloon comprising a therapeutic formulation which includes a therapeutic agent and an adhesion additive. The adhesion additive promotes... |
|
|
US20140316515 |
Method for producing a bioactive surface on an endoprosthesis or on the balloon of a balloon catheter
In a method for producing a bioactive surface on an endoprosthesis or on the balloon of a balloon catheter, the surface of the endoprosthesis or the surface of the balloon is softened. The surface... |
|
|
US20120239139 |
MEDICAL IMPLANTS CONTAINING FK506 (TACROLIMUS) METHODS OF MAKING AND METHODS OF USE THEREOF
Implants and methods of making same are provided for treatment or prophylaxis of coronary or peripheral vascular constrictions or vascular occlusions, and particularly, stenoses or restenoses,... |
|
|
US20120016465 |
Biodegradable Extravascular Stent
The present invention relates to extravascular supports. In particular, to extravascular supports which are used in vein grafting. More in particular, it relates to extravascular supports which... |
|
|
US20110137404 |
INFLATABLE POROUS IMPLANTS AND METHODS FOR DRUG DELIVERY
The present invention provides inflatable porous implants, such as grafts, stent-grafts, and bladders, as well as methods and kits for drug delivery. In particular, the grafts and stent-grafts of... |
|
|
US20110307047 |
SYSTEM AND METHODS FOR TREATING A BIFURCATION
A system for treating a bifurcation includes first and second delivery catheters, each having an expandable member and a stent. The stent on the second delivery catheter has a side hole. A portion... |
|
|
US20110251677 |
Coating Designs For The Tailored Release Of Dual Drugs From Polymeric Coatings
Provided herein are coating designs for the tailored release of two therapeutic agents from polymer coatings and methods of making and using the same. |
|
|
US20120071966 |
DRUG-RELEASING STENT WITH CERAMIC-CONTAINING LAYER
A vascular or endoluminal stent is adapted to be implanted in a vessel, duct or tract of a human body to maintain an open lumen. The stent includes a base layer of a biologically compatible metal.... |
|
|
US20110229548 |
Implantable Medical Device With Poly(Vinylidene Fluoride-Co-Hexafluoropropylene)/Zotarolimus Drug Layer
This invention relates to an implantable medical device for and method of treating a vascular disease where the device is preferably a stent comprising a drug reservoir layer comprising... |
|
|
US20110034993 |
COATED MEDICAL IMPLANTS
Coated medical devices are disclosed. In certain embodiments of the invention, the coating materials include therapeutic agents, polymers, sugars, waxes, or fats. In certain embodiments of the... |
|
|
US20130023982 |
STENT
A stent is configured to facilitate directional proliferation of cells on the inner surface of the stent to relatively quickly coat the stent surface with the cells so that the onset of late stent... |
|
|
US20110264187 |
Drug Eluting Folded Stent and Stent Delivery System
The drug eluting folded stent and a stent delivery system, which includes a stent having a plurality of struts interconnected to form a tubular body. At least one of the struts includes a U-shaped... |
|
|
US20110202125 |
ARTIFICIAL STENT AND ITS PREPARATION METHOD
An artificial stent and its preparation method. The artificial stent comprises a stent body and a coating on it. The artificial stent is characterized in that the coating comprises a drug-loaded... |
|
|
US20110009955 |
COMPOUNDS AND METHOD FOR COATING SURFACES IN A HEMOCOMPATIBLE MANNER
The invention concerns oligosaccharides and polysaccharides as well as the use of these oligosaccharides and/or polysaccharides, which contain the sugar unit N-acylglucosamine or... |
|
|
US20110251670 |
EXPANDABLE STENT THAT COLLAPSES INTO A NON-CONVEX SHAPE AND EXPANDS INTO AN EXPANDED, CONVEX SHAPE
An expandable stent that can transform between a collapsed state and an expanded state is described. The stent includes a first cross-sectional shape and a second cross-sectional shape. The first... |
|
|
US20150112299 |
Magnetically-Controllable Delivery System for Therapeutic Agents
A magnetic delivery system for delivering a magnetizable particle to a location in a body, the device includes a magnetizable object implanted in the body, wherein the magnetizable object includes... |
|
|
US20120016466 |
ABLUMINALLY COATED DRUG-ELUTING STENTS HAVING A FORM-FITTING PROTECTIVE LAYER
A drug-eluting stent, comprising a base body that is made of an implant material, the base body being partially or entirely covered on the abluminal side with an active ingredient-releasing... |
|
|
US20120316633 |
Durable Stent Drug Eluting Coating
In embodiments, medical devices, such stents, can deliver a therapeutic agent to body tissue of a patient. The medical device includes a porous therapeutic layer that is substantially free of a... |
|
|
US20120226347 |
Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered... |
|
|
US20130013048 |
MULTIPLE DRUG DELIVERY FROM A BALLOON AND A PROSTHESIS
Disclosed is an interventional device for delivery of therapeutic agents from an angioplasty balloon and from a prosthesis such as an intraluminal stent. The invention also relates to the method... |
|
|
US20120303112 |
STENT
The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or... |
|
|
US20110166646 |
Drug Eluting Stent and Method of Making the Same
A drug eluting stent comprising a multilayer tubular structure which includes at least one intermediate layer having reservoirs therein for deposition of a drug, the intermediate layer eluting... |
|
|
US20130274869 |
IMPLANT AND METHOD FOR MANUFACTURING SAME
A method for manufacturing an implant and an implant, in particular an intraluminal endoprosthesis, including a body having a coating on at least a portion of the surface thereof, and the... |
|
|
US20150134047 |
SAFE DRUG ELUTING STENT WITH ABSORBABLE COATING
Provided herein is a device comprising: a. stent; b. a plurality of layers on said stent framework to form said device; wherein at least one of said layers comprises a bioabsorbable polymer and at... |
|
|
US20110319984 |
Rejuvenation or preservation of germ cells
Certain embodiments disclosed herein include, but are not limited to, at least one of compositions, methods, devices, systems, kits, or products regarding rejuvenation or preservation of germ... |
|
|
US20110245915 |
IGF-I FOR MYOCARDIAL REPAIR
Provided herein are methods for treating an individual having (suffering from) an acute myocardial infarction and drug eluting stents useful for treating such individuals. These methods include... |
|
|
US20140271533 |
In-Situ Forming Foam for the Treatment of Vascular Dissections
Systems and methods related to polymer foams for the treatment of blood vessel dissections are generally described. Some embodiments relate to compositions and methods for the preparation of... |
|
|
US20110172763 |
Matrix Coated Stent
The present invention relates generally to a drug eluting stent containing metallic surfaces modified in microsphere metallic matrix structure and methods for making same. More specifically, the... |
|
|
US20120165922 |
METHOD OF MODIFYING A COATING ON A MEDICAL DEVICE
Method of modifying the coating of a surface of a medical device by applying a coating to the surface of the medical device, exposing the medical device to an environmental condition that alters... |
|
|
US20050182384 |
Flushing cannula with integral catheter sheath
The invention provides a catheter flushing device. The device comprises a syringe fitting, a hollow stylet, and a sleeve. The hollow stylet is attached to and in fluid communication with the... |
|
|
US20130238085 |
SILVER NANOPARTICLE ANTIMICROBIAL COATING FOR LONG-TERM AND SHORT-TERM INFECTION RESISTANCE
Disclosed herein is an implantable medical device including an antimicrobial layer. The antimicrobial layer may include a first distinct size of silver nanoparticles, a second distinct size of... |
|
|
US20110153004 |
POLY(ESTER AMIDE)-BASED DRUG DELIVERY SYSTEMS WITH CONTROLLED RELEASE RATE AND MORPHOLOGY
A method of forming a coating on a medical device having a controlled morphology is described. A method of treating a disorder in a patient using the medical device is described. |
|
|
US20120121659 |
FUNCTIONALIZED RGD PEPTIDOMIMETICS AND THEIR MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING SUCH FUNCTIONALIZED RGD PEPTIDOMIMETICS
At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a... |
|
|
US20140296967 |
DRUG ELUTING STENT WITH A BIODEGRADABLE RELEASE LAYER ATTACHED WITH AN ELECTRO-GRAFTED PRIMER COATING
The present invention provides a drug eluting stent including a metallic stent framework, an electro-grafted primer coating disposed on the stent framework; and a biodegradable polymer coating... |
|
|
US20090216320 |
Magnetic Gradient Targeting And Sequestering Of Therapeutic Formulations And Therapeutic Systems Thereof
A therapeutic system and a method that uses stents, and/or other implantable devices (104) for local delivery of a therapeutic agent is disclosed. A therapeutic formulation (102) may include... |
|
|
US20110276123 |
VASCULAR STENT DESIGN
This invention is directed to the design of radially expandable vascular stents to optimize hemodynamic flow characteristics that are favorable for the inhibition of stent-associated thrombosis,... |
|
|
US20110218611 |
DRUG ELUTING STENT AND A GUIDE CATHETER DEVICE ASSEMBLY FOR IMPLANTING THE SAME
The present invention relates to a drug eluting stent for delivering therapeutic agents to a body lumen. The stent includes an expandable substrate configured for implantation in a vessel of a... |
|
|
US20130053947 |
Medical Device with Crystalline Drug Coating
A medical device having a polymer-free outer surface layer comprising a crystalline drug selected from the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and... |
|
|
US20120165923 |
STENT
A stent able to minimize occurrences of strain and stress concentration in a drug coat layer upon expansive deformation of the stent in a radial direction to avoid the possibility of the drug... |
|
|
US20080140176 |
Medical stent and devices for localized treatment of disease
A medical device for treatment of a stenosed body lumen includes an open-ended cylindrical body movable between a collapsed position and a radially expanded position pressed against the wall of... |
|
|
US20140030308 |
IMPLANTS AND PROCEDURES FOR PROMOTING AUTOLOGOUS STEM CELL GROWTH
A biologically engineered stent for treating patients suffering from acute myocardial infarction/ischemia. The stent is inserted in a vessel upstream to and proximal the damaged muscle/ischemic... |
|
|
US20110015724 |
MEDICAL DEVICE HAVING HYDROPHILIC COATINGS
The present invention relates to a medical device having a coating comprising at least one polyurethane urea, wherein the coating comprises at least one polyurethane urea terminated with a... |
|
|
US20100331970 |
Compounds and Methods for the Prevention or Treatment of Restenosis
A method for the prophylaxis or treatment of restenosis comprising administering a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof to a patient in need... |
|
|
US20110251663 |
Drug Eluting Rolled Stent and Stent Delivery System
The drug eluting rolled stent and a stent delivery system, which includes a catheter; a balloon operably attached to the catheter; and a stent disposed on the balloon. The stent includes a... |
|
|
US20120265295 |
INTRAVASCULAR STENT AND METHOD OF USE
An expandable stent is implanted in a body lumen, such as a coronary artery, peripheral artery, or other body lumen for treating an area of vulnerable plaque. The invention provides for a an... |